OCD

View Details
logo
Parent item

Numbers

  • Prevalence of 1-3% of the population

Clinical features

  • Characterized by recurrent, intrusive anxious thoughts (obsessions) accompanied by repetitive stereotyped behaviours or mental routines (compulsions) that are frequently performed in an effort to reduce distress caused by obsessions.
    • Can affect quality of life
      • Interpersonal relationships, social and occupational functioning
      • Ability to carry out basic activities of daily living;
  • Associated with a higher lifetime risk of
    • Suicide (up to 27% of patients)
    • Major depression.

Mechanism

  • Functional neuroimaging studies:
    • Corticostriatal-thalamocortical circuitry abnormalities
      • In the form of
        • Failure of inhibition within basal ganglia–thalamocortical loops
        • Abnormal signalling of dopamine and GABA.
      • Subsets of projection neurons become active in inappropriate contexts as a result of dysfunctional inhibitory GABA interneurons within the striatum → disinhibition of thalamocortical projections and increased excitability of both motor and limbic regions → inappropriate expression of sensory and motor phenomena, i.e. tics.
  • Increased metabolic activity in the
    • Orbitofrontal cortex (OFC)
    • Caudate nucleus (particularly its ventral division)
      • OFC and caudate hyperactivity are directly correlated with symptom severity, and these changes partially normalize with successful treatment.
    • Anterior cingulate cortex (ACC)
    • Medial prefrontal cortex

Treatment

  • Non-surgical
    • Pharmacotherapy
      • SSRI
    • Psychotherapy
      • CBT
      • Exposure and response prevention).
    • Outcome
      • 50% of OCD patients do not obtain adequate benefit with standard treatment approaches
      • 10% experience severe treatment-refractory symptoms.
  • DBS
    • Target
      • From
        • Lesional psychosurgery procedures
        • Following observations of response to surgery for other conditions (e.g. STN DBS for PD)
        • Gradual target refinement following ongoing evaluation of clinical outcomes in relation to lead location.
      • Anterior limb of the internal capsule
      • Nucleus accumbens
      • Ventral capsule/ventral striatum
      • STN
      • Inferior thalamic peduncle